GCTK
Glucotrack, Inc.
NASDAQ · Healthcare · Medical - Instruments & Supplies · IL
$2.47
+3.78%Price chart
Aug 19Aug 24Aug 27Sep 1Sep 4Sep 10Sep 15Sep 18
Key dataSep 18, 2026
Open$2.45
From 52W high−98.08%
Volume27303.00
Market cap$1.97M
P/E (TTM)—
P/S (TTM)—
Div yield—
Key dataSep 18, 2026
Open
$2.45
From 52W high
−98.08%
Volume
27303.00
Market cap
$1.97M
ValuationView details →
P/E (Fwd)
—
EV/EBITDA
−0.1x
P/E (TTM)
—
RSI (14)
33.1
MomentumView details →
1D Return
+3.78%
YTD Return
−95.80%
SummaryUpdated Jun 1, 2026
GlucoTrack, Inc. (NASDAQ:GCTK) is an Israeli medical device company founded in 2001 and headquartered in Or Yehuda, Israel. Originally established as Integrity Applications, Inc., the company rebranded to GlucoTrack in November 2021 to better reflect its focus on glucose monitoring technology. The company went public in April 2013 and specializes in developing non-invasive glucose monitoring devices for people with diabetes and pre-diabetes. Despite over two decades of development, GlucoTrack has yet to generate commercial revenue and remains in the research and development phase of bringing its flagship product to market.
Similar companies
Latest newsMore news →
Paul V. Goode resigned as a director of Glucotrack, Inc., effective September 14, 2026.2d agoGlucotrack, Inc. amended its common warrants so that holders cannot exercise them until the company obtains stockholder approval for the issuance of all shares underlying the warrants under Nasdaq Listing Rule 5635(d).6d agoGlucotrack, Inc. engaged Dawson James Securities, Inc. as placement agent under a Placement Agency Agreement with a 7% cash fee and warrants to purchase 148,668 shares.9d ago